You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

treatment-naïve chronic lymphocytic leukemia

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Lymphocytic Leukemia Trial (Acalabrutinib, Obinutuzumab)

Not yet recruiting
  • Chronic Lymphocytic Leukemia
  • (no location specified)
Jul 10, 2023

Leukemia Trial in Houston (Pirtobrutinib, Obinutuzumab, Venetoclax)

Not yet recruiting
  • Leukemia
  • Houston, Texas
    M D Anderson Cancer Center
Sep 7, 2022

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Columbus (Acalabrutinib, Obinutuzumab, Venetoclax)

Recruiting
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Nov 2, 2022

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial run by the (Acalabrutinib (Arm A), Acalabrutinib (Arm B))

Active, not recruiting
Has Results
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • Acalabrutinib (Arm A)
  • Acalabrutinib (Arm B)
  • Bethesda, Maryland
    Research Site
Jan 3, 2023

Hepatitis, Safety and Tolerability Trial run by the NHLBI (HEPLISAV-B)

Completed
Has Results
  • Hepatitis
  • Safety and Tolerability
  • HEPLISAV-B
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 13, 2022

Chronic Lymphocytic Leukemia (CLL) Trial (Venetoclax, Rituximab, Ibrutinib)

Not yet recruiting
  • Chronic Lymphocytic Leukemia (CLL)
  • (no location specified)
Apr 2, 2022

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Houston (Acalabrutinib, Obinutuzumab)

Recruiting
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • Houston, Texas
    M D Anderson Cancer Center
Jul 14, 2022

Relapsed/Refractory B Cell Malignancies, Mantle Cell Lymphoma and Diffuse Large B Cell Lymphoma, Chronic Lymphocytic Leukemia

Active, not recruiting
  • Relapsed/Refractory B Cell Malignancies
  • +3 more
  • Columbus, Ohio
  • +17 more
Aug 18, 2022

Chronic Lymphocytic Leukemia Trial in Houston (Ofatumumab)

Active, not recruiting
  • Chronic Lymphocytic Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Feb 23, 2022

Follicular Lymphoma, Small Lymphocytic Lymphoma Trial in Fort Myers, Saint Petersburg, Nashville (Ublituximab, Umbralisib)

Terminated
  • Follicular Lymphoma
  • Small Lymphocytic Lymphoma
  • Fort Myers, Florida
  • +2 more
Jul 20, 2022

Chronic Lymphocytic Leukemia Trial in Milano (Ibrutinib and obinutuzumab)

Recruiting
  • Chronic Lymphocytic Leukemia
  • Ibrutinib and obinutuzumab
  • Milano, MI, Italy
    Strategic Research Program on CLL
Apr 2, 2022

Chronic Lymphocytic Leukemia Trial in Columbus (biological, drug, other)

Recruiting
  • Chronic Lymphocytic Leukemia
  • Daratumumab
  • +3 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Feb 24, 2022

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial run by the NHLBI (Ibrutinib, Fludarabine)

Active, not recruiting
Has Results
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Mar 1, 2022

Safety and Tolerability, Compare SHINGRIX Vaccine Response Rates, Chronic Lymphocytic Leukemia (CLL) Trial run by the NHLBI

Active, not recruiting
Has Results
  • Safety and Tolerability
  • +3 more
  • Zoster Vaccine Recombinant, Adjuvanted
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 10, 2022

Leukemia, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Worldwide (ibrutinib, venetoclax, Placebo)

Active, not recruiting
Has Results
  • Leukemia
  • +2 more
  • Duarte, California
  • +45 more
Jan 27, 2022

Chronic Lymphocytic Leukemia (CLL) Trial in Chicago (Oncoquest-CLL vaccine)

Active, not recruiting
  • Chronic Lymphocytic Leukemia (CLL)
  • Oncoquest-CLL vaccine
  • Chicago, Illinois
    Robert H. Lurie Comprehensive Cancer Center at Northwestern Univ
Apr 7, 2021

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Relapsed Chronic Lymphocytic Leukemia Trial in Boston (Acalabrutinib,

Active, not recruiting
  • Chronic Lymphocytic Leukemia
  • +3 more
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Dec 19, 2022

Chronic Lymphocytic Leukemia Trial (Loncastuximab Tesirine)

Not yet recruiting
  • Chronic Lymphocytic Leukemia
  • Loncastuximab Tesirine
  • (no location specified)
Jul 24, 2023

Treatment Pathway in Chronic Lymphocytic Leukemia

Recruiting
  • Chronic Lymphocytic Leukemia
    • Argentina, Argentina
    • +17 more
    Aug 9, 2022

    Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial (Nemtabrutinib, Ibrutinib, Acalabrutinib)

    Not yet recruiting
    • Chronic Lymphocytic Leukemia
    • Small Lymphocytic Lymphoma
    • (no location specified)
    Nov 22, 2023

    Leukemia, Lymphocytic, Chronic, B-Cell, Small Lymphocytic Lymphoma Trial (Ibrutinib, Venetoclax)

    Not yet recruiting
    • Leukemia, Lymphocytic, Chronic, B-Cell
    • Small Lymphocytic Lymphoma
    • (no location specified)
    Jul 19, 2023

    Chronic Lymphocytic Leukemia Patients

    Not yet recruiting
    • Chronic Lymphocytic Leukemia
      • San Francisco, California
        Power Life Sciences
      Jun 2, 2023

      Orelabrutinib in the Treatment of CLL/SLL

      Not yet recruiting
      • CLL/SLL
        • (no location specified)
        Jul 26, 2023

        Chronic Lymphoid Leukemia Trial in Austria, Germany (Acalabrutinib)

        Recruiting
        • Chronic Lymphoid Leukemia
        • Acalabrutinib
        • Innsbruck, Austria
        • +19 more
        Mar 21, 2022

        Recurrent Chronic Lymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma, Refractory Chronic Lymphocytic Leukemia Trial in

        Recruiting
        • Recurrent Chronic Lymphocytic Leukemia
        • +3 more
        • Houston, Texas
          M D Anderson Cancer Center
        Aug 17, 2022